MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

Item

http://www.wikidata.org/entity/Q41149988

Q41149988

about

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis Deconstructing innate immune signaling in myelodysplastic syndromes Recurrent mutations refine prognosis in chronic lymphocytic leukemia.The Role of Toll-Like Receptors in Hematopoietic Malignancies Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.Candidate genes of Waldenström's macroglobulinemia: current evidence and research.Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma.Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance.Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom's Macroglobulinemia.Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia.Waldenström macroglobulinaemia: the key questions.XIII. Waldenström's macroglobulinaemia: an indolent B-cell lymphoma with distinct molecular and clinical features.Lessons from next-generation sequencing analysis in hematological malignancies.Regulation of hematopoietic stem cell activity by inflammation.Genetic factors and pathogenesis of Waldenström's macroglobulinemia.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models Waldenström macroglobulinemia: from biology to treatment.MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström's Macroglobulinemia.Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression.Disease-specific mutations in mature lymphoid neoplasms: recent advances.Toll-like receptors and B cells: functions and mechanisms.Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases.Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.

P2860

Q26778403-F5941DC0-0AD4-4A79-AC20-E6B1691577EB Q26991974-EB3AE816-FA40-466A-8D7E-94F379EFADCD Q27853022-FABAB163-0EA1-453C-B46E-AA74FFF44CF3 Q28077740-C15FCC26-F79D-48B5-BEEE-4C58F465E7F7 Q30299913-B3B1C755-84F5-42FC-A814-801A88FC1DD9 Q30459093-BD76A88D-A625-41A7-810C-2450E80C3A5F Q33408517-C2C4F5A2-35EC-4D47-844F-01896CD735C9 Q33414529-994CBF2C-4035-47E3-A5F2-1CB61757A2F8 Q33421444-BE567228-C00A-45D2-A1B6-B6FB16BF0156 Q33438490-32835DE6-C2F9-4513-BBB5-FBED862ADDC9 Q33617237-280BDEC9-3A44-4523-9294-41E2732B1CC9 Q33660823-96311E96-B148-4BFD-A64F-47BF7A6D694C Q34101118-CC02C9EB-EFD3-463F-9B31-510DD6C7B86F Q34435295-454357B7-14EF-465E-874A-329B0D0E54E0 Q35041614-11C6371C-24F0-449C-ACDE-CCA226B8C3D9 Q35767684-57E07222-4CD6-410A-931E-474830D84A3B Q36058393-55FAF9E9-088C-4A01-8B06-C73619A1CC53 Q36533710-95FB84B1-2FF4-4452-B227-C4993BECC51C Q36965870-192F629D-92AD-413E-88C4-F05CB5F52E4E Q37074275-B1E5B7C5-4F94-4DE7-87B9-66C52730CBEA Q37318677-8CB59A4C-9F59-44EF-994A-A6F2725DB6CC Q37621361-C0F44186-8D34-4AE3-8BB6-FF2C9EB7F3C0 Q37630211-B7FF59AC-8FE1-47A5-92B6-0B77983F0CCC Q37670820-C681B68C-702D-415F-8DD5-B9561B5F2E0D Q37685724-8BA248DF-D760-4CEA-956C-39277FA060CC Q37723475-89A7212E-D7D0-4B37-9330-EDDC6F8C4F8B Q38104808-296786CF-77D7-43D5-84B4-58933DE0C996 Q38115233-F70C8F60-0A15-4B2E-B74B-A6896CE3622B Q38123015-10CCBE2F-CCA3-4298-B3F7-758991E765BB Q38123812-EAD8ECAB-4261-48A4-B0B4-971A49AC5DE2 Q38125430-31B9B821-2006-48EC-8A5F-39A6CEB3FC13 Q38150849-E542E9A4-F5AD-4F61-B0D7-DE07D3CA2EFC Q38176969-E26CDDA8-6963-4913-A649-1C316057223F Q38191449-A54DEE77-985E-439A-BEE3-DC222BFBBB70 Q38199534-F88EEFF6-CA3E-46C1-B137-215666023FE5 Q38201143-DC803CF8-F5D7-43C3-96C9-37ABE51A3FAB Q38213432-84A4BDDA-BA38-4655-80A8-4E77DB2D1986 Q38571471-A7742A52-137B-458C-947D-EA0D8CD515AD Q38663689-38B6F34C-2258-4C43-8533-567C5668F8A3 Q38747789-20794FE7-A499-4751-8587-6D44256108CD

P2860

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

Item

http://www.wikidata.org/entity/Q41149988

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

MYD88 L265P in Waldenström mac ...... ific polymerase chain reaction

@en

type

Item

label

MYD88 L265P in Waldenström mac ...... ific polymerase chain reaction

@en

prefLabel

MYD88 L265P in Waldenström mac ...... ific polymerase chain reaction

@en

P1476

MYD88 L265P in Waldenström mac ...... ific polymerase chain reaction

@en

P2093

Alessandra Trojani

http://www.w3.org/2001/XMLSchema#string

Antonino Greco

http://www.w3.org/2001/XMLSchema#string

Christina K Tripsas

http://www.w3.org/2001/XMLSchema#string

Christopher J Patterson

http://www.w3.org/2001/XMLSchema#string

Enrica Morra

http://www.w3.org/2001/XMLSchema#string

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Jennifer R Brown

http://www.w3.org/2001/XMLSchema#string

Lian Xu

http://www.w3.org/2001/XMLSchema#string

Luca Arcaini

http://www.w3.org/2001/XMLSchema#string

Marzia Varettoni

http://www.w3.org/2001/XMLSchema#string

P2860

IKAP is a scaffold protein of the IkappaB kinase complex

Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia

Targeting NF-kappaB in Waldenstrom macroglobulinemia

Oncogenically active MYD88 mutations in human lymphoma

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Analysis of the coding genome of diffuse large B-cell lymphoma

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

P304

2051-2058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-09-454355

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth C Anderson

P577

2013-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234141497

http://www.w3.org/2001/XMLSchema#string

P698

23321251

http://www.w3.org/2001/XMLSchema#string

P932

3596964

http://www.w3.org/2001/XMLSchema#string

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

about

P2860

P2860

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932